MAUDE Adverse Event Report: B. BRAUN MELSUNGEN AG INTROCAN 3; CATHETER, INTRAVASCULAR, THERAPEUTIC, SHORT-TERM LESS THAN 30 DAYS
-
|
|
|
New Search | Submit an Adverse Event Report |
|
-